Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA staff: Sanofi/Regeneron drug lowers LDL; is well tolerated
FDA staff: Sanofi/Regeneron drug lowers LDL; is well tolerated
FDA staff: Sanofi/Regeneron drug lowers LDL; is well tolerated
Submitted by
admin
on June 5, 2015 - 9:20am
Source:
Yahoo/Reuters
News Tags:
FDA
Sanofi
Regeneron
alirocumab
advisory panels
Headline:
FDA staff: Sanofi/Regeneron drug lowers LDL; is well tolerated
Do Not Allow Advertisers to Use My Personal information
